A citation-based method for searching scientific literature

Alberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, Cristina Chiva, Daniel Balateu-Paños, Martí Colom-Cadena, Gemma Gomez-Giro, Laia Muñoz, Marta Querol-Vilaseca, Jordi Pegueroles, Lorena Rami, Albert Lladó, José L Molinuevo, Mikel Tainta, Jordi Clarimón, Tara Spires-Jones, Rafael Blesa, Juan Fortea, Pablo Martínez-Lage, Raquel Sánchez-Valle, Eduard Sabidó, Àlex Bayés, Olivia Belbin. Mol Cell Proteomics 2019
Times Cited: 58







List of co-cited articles
589 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.
Alberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, Cristina Chiva, Daniel Balateu-Paños, Martí Colom-Cadena, Gemma Gomez-Giro, Laia Muñoz, Marta Querol-Vilaseca, Jordi Pegueroles,[...]. Mol Cell Proteomics 2019
33
69

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.
R D Terry, E Masliah, D P Salmon, N Butters, R DeTeresa, R Hill, L A Hansen, R Katzman. Ann Neurol 1991
34

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
20

Increased CSF neurogranin concentration is specific to Alzheimer disease.
Henrietta Wellington, Ross W Paterson, Erik Portelius, Ulrika Törnqvist, Nadia Magdalinou, Nick C Fox, Kaj Blennow, Jonathan M Schott, Henrik Zetterberg. Neurology 2016
127
20

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
20


Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Rawan Tarawneh, Gina D'Angelo, Dan Crimmins, Elizabeth Herries, Terry Griest, Anne M Fagan, Gregory J Zipfel, Jack H Ladenson, John C Morris, David M Holtzman. JAMA Neurol 2016
113
18


Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Erik Portelius, Henrik Zetterberg, Tobias Skillbäck, Ulrika Törnqvist, Ulf Andreasson, John Q Trojanowski, Michael W Weiner, Leslie M Shaw, Niklas Mattsson, Kaj Blennow. Brain 2015
157
17

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease.
Ann Brinkmalm, Gunnar Brinkmalm, William G Honer, Lutz Frölich, Lucrezia Hausner, Lennart Minthon, Oskar Hansson, Anders Wallin, Henrik Zetterberg, Kaj Blennow,[...]. Mol Neurodegener 2014
146
17

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.
Flora H Duits, Gunnar Brinkmalm, Charlotte E Teunissen, Ann Brinkmalm, Philip Scheltens, Wiesje M Van der Flier, Henrik Zetterberg, Kaj Blennow. Alzheimers Res Ther 2018
58
15

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.
Erik Portelius, Bob Olsson, Kina Höglund, Nicholas C Cullen, Hlin Kvartsberg, Ulf Andreasson, Henrik Zetterberg, Åsa Sandelius, Leslie M Shaw, Virginia M Y Lee,[...]. Acta Neuropathol 2018
82
15

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.
E Masliah, M Mallory, M Alford, R DeTeresa, L A Hansen, D W McKeel, J C Morris. Neurology 2001
493
15

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.
Kristin R Wildsmith, Stephen P Schauer, Ashley M Smith, David Arnott, Yuda Zhu, Joshua Haznedar, Surinder Kaur, W Rodney Mathews, Lee A Honigberg. Mol Neurodegener 2014
91
15

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression.
Ilijana Begcevic, Magda Tsolaki, Davor Brinc, Marshall Brown, Eduardo Martinez-Morillo, Ioulietta Lazarou, Mahi Kozori, Fani Tagaraki, Stella Nenopoulou, Mara Gkioka,[...]. F1000Res 2018
21
42

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.
Gunnar Brinkmalm, Simon Sjödin, Anja Hviid Simonsen, Steen Gregers Hasselbalch, Henrik Zetterberg, Ann Brinkmalm, Kaj Blennow. Proteomics Clin Appl 2018
62
15

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
Hlin Kvartsberg, Flora H Duits, Martin Ingelsson, Niels Andreasen, Annika Öhrfelt, Kerstin Andersson, Gunnar Brinkmalm, Lars Lannfelt, Lennart Minthon, Oskar Hansson,[...]. Alzheimers Dement 2015
197
13


NPTX2 and cognitive dysfunction in Alzheimer's Disease.
Mei-Fang Xiao, Desheng Xu, Michael T Craig, Kenneth A Pelkey, Chun-Che Chien, Yang Shi, Juhong Zhang, Susan Resnick, Olga Pletnikova, David Salmon,[...]. Elife 2017
86
13

Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.
Katarzyna Lepeta, Mychael V Lourenco, Barbara C Schweitzer, Pamela V Martino Adami, Priyanjalee Banerjee, Silvina Catuara-Solarz, Mario de La Fuente Revenga, Alain Marc Guillem, Mouna Haidar, Omamuyovwi M Ijomone,[...]. J Neurochem 2016
145
13

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease.
Douglas Galasko, Meifang Xiao, Desheng Xu, Denis Smirnov, David P Salmon, Nele Dewit, Jeroen Vanbrabant, Dirk Jacobs, Hugo Vanderstichele, Eugeen Vanmechelen,[...]. Alzheimers Dement (N Y) 2019
41
19

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
Adam P Mecca, Ming-Kai Chen, Ryan S O'Dell, Mika Naganawa, Takuya Toyonaga, Tyler A Godek, Joanna E Harris, Hugh H Bartlett, Wenzhen Zhao, Nabeel B Nabulsi,[...]. Alzheimers Dement 2020
77
13

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.
Annika Thorsell, Maria Bjerke, Johan Gobom, Eva Brunhage, Eugeen Vanmechelen, Niels Andreasen, Oskar Hansson, Lennart Minthon, Henrik Zetterberg, Kaj Blennow. Brain Res 2010
144
12

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.
Stephen W Scheff, Douglas A Price, Frederick A Schmitt, Elliott J Mufson. Neurobiol Aging 2006
628
12

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Bob Olsson, Ronald Lautner, Ulf Andreasson, Annika Öhrfelt, Erik Portelius, Maria Bjerke, Mikko Hölttä, Christoffer Rosén, Caroline Olsson, Gabrielle Strobel,[...]. Lancet Neurol 2016
935
12

Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Ming-Kai Chen, Adam P Mecca, Mika Naganawa, Sjoerd J Finnema, Takuya Toyonaga, Shu-Fei Lin, Soheila Najafzadeh, Jim Ropchan, Yihuan Lu, Julia W McDonald,[...]. JAMA Neurol 2018
182
12

Fluid Biomarkers for Synaptic Dysfunction and Loss.
Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, Bruno Becker, Nicholas J Ashton, Kaj Blennow, Henrik Zetterberg. Biomark Insights 2020
25
28

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.
Annika Öhrfelt, Ann Brinkmalm, Julien Dumurgier, Gunnar Brinkmalm, Oskar Hansson, Henrik Zetterberg, Elodie Bouaziz-Amar, Jacques Hugon, Claire Paquet, Kaj Blennow. Alzheimers Res Ther 2016
74
10

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.
Hlin Kvartsberg, Tammaryn Lashley, Christina E Murray, Gunnar Brinkmalm, Nicholas C Cullen, Kina Höglund, Henrik Zetterberg, Kaj Blennow, Erik Portelius. Acta Neuropathol 2019
42
14

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.
Gajanan Sathe, Chan Hyun Na, Santosh Renuse, Anil K Madugundu, Marilyn Albert, Abhay Moghekar, Akhilesh Pandey. Proteomics Clin Appl 2019
41
14

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
Katya Rascovsky, John R Hodges, David Knopman, Mario F Mendez, Joel H Kramer, John Neuhaus, John C van Swieten, Harro Seelaar, Elise G P Dopper, Chiadi U Onyike,[...]. Brain 2011
10

Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons.
Kenneth A Pelkey, Elizabeth Barksdale, Michael T Craig, Xiaoqing Yuan, Madhav Sukumaran, Geoffrey A Vargish, Robert M Mitchell, Megan S Wyeth, Ronald S Petralia, Ramesh Chittajallu,[...]. Neuron 2015
110
10

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.
Daniel S Spellman, Kristin R Wildsmith, Lee A Honigberg, Marianne Tuefferd, David Baker, Nandini Raghavan, Angus C Nairn, Pascal Croteau, Michael Schirm, Rene Allard,[...]. Proteomics Clin Appl 2015
78
10

Presynaptic Neuronal Pentraxin Receptor Organizes Excitatory and Inhibitory Synapses.
Sung-Jin Lee, Mengping Wei, Chen Zhang, Stephan Maxeiner, ChangHui Pak, Salome Calado Botelho, Justin Trotter, Fredrik H Sterky, Thomas C Südhof. J Neurosci 2017
65
10

Complement and microglia mediate early synapse loss in Alzheimer mouse models.
Soyon Hong, Victoria F Beja-Glasser, Bianca M Nfonoyim, Arnaud Frouin, Shaomin Li, Saranya Ramakrishnan, Katherine M Merry, Qiaoqiao Shi, Arnon Rosenthal, Ben A Barres,[...]. Science 2016
10

Neuropathological alterations in Alzheimer disease.
Alberto Serrano-Pozo, Matthew P Frosch, Eliezer Masliah, Bradley T Hyman. Cold Spring Harb Perspect Med 2011
10

Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
Borislav Dejanovic, Melanie A Huntley, Ann De Mazière, William J Meilandt, Tiffany Wu, Karpagam Srinivasan, Zhiyu Jiang, Vineela Gandham, Brad A Friedman, Hai Ngu,[...]. Neuron 2018
172
10

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
Åsa Sandelius, Erik Portelius, Åsa Källén, Henrik Zetterberg, Uros Rot, Bob Olsson, Jon B Toledo, Leslie M Shaw, Virginia M Y Lee, David J Irwin,[...]. Alzheimers Dement 2019
54
11

Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.
P Hemachandra Reddy, Geethalakshmi Mani, Byung S Park, Joline Jacques, Geoffrey Murdoch, William Whetsell, Jeffrey Kaye, Maria Manczak. J Alzheimers Dis 2005
269
10

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
Ann De Vos, Dirk Jacobs, Hanne Struyfs, Erik Fransen, Kerstin Andersson, Erik Portelius, Ulf Andreasson, Didier De Surgeloose, Daniëlle Hernalsteen, Kristel Sleegers,[...]. Alzheimers Dement 2015
92
10

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
Martí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, Kaj Blennow, Anthony Caggiano, Steven T DeKosky, Howard Fillit, John E Harrison, Lon S Schneider, Phillip Scheltens,[...]. Alzheimers Res Ther 2020
73
10

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.
Lenora Higginbotham, Lingyan Ping, Eric B Dammer, Duc M Duong, Maotian Zhou, Marla Gearing, Cheyenne Hurst, Jonathan D Glass, Stewart A Factor, Erik C B Johnson,[...]. Sci Adv 2020
44
13

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.
Niklas Mattsson, Philip S Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow, Oskar Hansson. EMBO Mol Med 2016
150
8

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.
Hlin Kvartsberg, Erik Portelius, Ulf Andreasson, Gunnar Brinkmalm, Konstantin Hellwig, Natalia Lelental, Johannes Kornhuber, Oskar Hansson, Lennart Minthon, Philipp Spitzer,[...]. Alzheimers Res Ther 2015
89
8

Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
Cristina Sanfilippo, Orestes Forlenza, Henrik Zetterberg, Kaj Blennow. J Neural Transm (Vienna) 2016
33
15

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Hua Zhang, Joseph Therriault, Min Su Kang, Kok Pin Ng, Tharick A Pascoal, Pedro Rosa-Neto, Serge Gauthier. Alzheimers Res Ther 2018
33
15

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
Heiko Braak, Irina Alafuzoff, Thomas Arzberger, Hans Kretzschmar, Kelly Del Tredici. Acta Neuropathol 2006
8

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.
Robert M Koffie, Melanie Meyer-Luehmann, Tadafumi Hashimoto, Kenneth W Adams, Matthew L Mielke, Monica Garcia-Alloza, Kristina D Micheva, Stephen J Smith, M Leo Kim, Virginia M Lee,[...]. Proc Natl Acad Sci U S A 2009
571
8

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.
Robert M Koffie, Tadafumi Hashimoto, Hwan-Ching Tai, Kevin R Kay, Alberto Serrano-Pozo, Daniel Joyner, Steven Hou, Katherine J Kopeikina, Matthew P Frosch, Virginia M Lee,[...]. Brain 2012
180
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.